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Endovascular Treatment for Iliac Vein
Compression Syndrome: a Comparison
between the Presence and Absence of
Secondary Thrombosis
Objective: To evaluate the value of early identification and endovascular treat-
ment of iliac vein compression syndrome (IVCS), with or without deep vein throm-
bosis (DVT).
Materials and Methods: Three groups of patients, IVCS without DVT (group 1,
n = 39), IVCS with fresh thrombosis (group 2, n = 52) and IVCS with non-fresh
thrombosis (group 3, n = 34) were detected by Doppler ultrasonography, magnetic
resonance venography, computed tomography or venography. The fresh venous
thrombosis were treated by aspiration and thrombectomy, whereas the iliac vein
compression per se were treated with a self-expandable stent. In cases with fresh
thrombus, the inferior vena cava filter was inserted before the thrombosis suction,
mechanical thrombus ablation, percutaneous transluminal angioplasty, stenting or
transcatheter thrombolysis. 
Results: Stenting was performed in 111 patients (38 of 39 group 1 patients and
73 of 86 group 2 or 3 patients). The stenting was tried in one of group 1 and in
three of group 2 or 3 patients only to fail. The initial patency rates were 95%
(group 1), 89% (group 2) and 65% (group 3), respectively and were significantly
different (p = 0.001). Further, the six month patency rates were 93% (group 1),
83% (group 2) and 50% (group 3), respectively, and were similarly significantly
different (p = 0.001). Both the initial and six month patency rates in the IVCS
patients (without thrombosis or with fresh thrombosis), were significantly greater
than the patency rates of IVCS patients with non-fresh thrombosis.
Conclusion: From the cases examined, the study suggests that endovascular
treatment of IVCS, with or without thrombosis, is effective.
liac vein compression syndrome (IVCS) is a clinical syndrome which
causes lower extremity swelling, pain, varicosities and other symptoms
resulting from pelvic and lower extremity venous flow obstruction
caused by the compression of the iliac vein by the overlying iliac artery. McMurrich
first discovered that the left leg swelling is caused by the left iliac vein compression in
1908. In 1956, May and Thurner described, for the first time, the anatomical features
of this disease which was then named the May-Thurner syndrome (1, 2). In 1965,
Cockett and Thomas reported the pathology and clinical features of this syndrome and
named it the IVCS. Since then, many people have called this syndrome the Cockett
syndrome. IVCS is not only the main cause of dysfunction in the deep venous valve
and varicosities, but also the main cause of iliofemoral vein thrombosis and an
important factor contributing to the higher number of deep-vein thrombosis (DVT)
cases in the left extremity (3). The surgical treatment of IVCS has been progressing
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Iembolectomy method into practice in subsequent thrombo-
sis cases. Furthermore, over the last 20 years, the rapid
development of vascular imaging and intravascular
interventional therapy enabled the improvement of
diagnosis and microinvasive treatment of the IVCS and
secondary thrombosis (6, 7). We present our retrospective
data from 125 patients to evaluate and compare the effects




One hundred twenty-five cases with IVCS (50 males, 75
females, age range 18-75 yrs, mean 52.5 yrs), with or
without DVT, were enrolled in this study. The exclusion
criteria included some other causes of DVT such as
malignancy, recent limb trauma, recent surgery (except for
great saphenous vein stripping) and estrogen therapy.
IVCS is a condition defined by a greater than 50% stenosis
or occlusion of the common iliac vein, accompanied with
significant venous collateral vessels. We did not routinely
measure venous pressure at our institution as we consider
these measurements of lesser value for patients in the
supine position. Contrast stasis and the predominant collat-
eral vein indicated that the hemodynamic significance of
iliac vein stenosis or obstruction. The duration of patient
symptoms, including leg swelling, pain and varicose veins,
ranged from one day to two months. The patient
demographic data are itemized in Table 1. 
Iliac vein compression syndrome without DVT was
detected in 39 patients by means of venous duplex
ultrasonography (n = 9), magnetic resonance venography
(n = 7), computed tomography (n = 19) or venography (n =
4), and confirmed by a femoral venogram. In total, we
diagnosed 12 patients before stripping the great saphenous
vein or endovascular closure, whereas nine cases were
diagnosed by a venography performed due to the aggrava-
tion of leg swelling after the stripping of the great
saphenous vein. The remaining 18 diagnosed IVCS cases
presented with isolated unilateral lower extremity edema.
In total, 32 cases occurred on the patient’s left side,
whereas seven cases occurred on the right side (left : right
= 4.6 : 1). 
Iliac vein compression syndrome was confirmed in 86
DVT patients by a venography after the aspiration or
mechanical thrombectomy, in which, 71 cases occurred on
the patient’s left side, whereas 15 cases occurred on the
right side (left : right = 4.7 : 1). Of the 86 diagnosed cases
of DVT, 26 were of the central type (involving the
common iliac, external iliac and common femoral vein)
and 60 were of the mixed type (involving the entire lower
extremity deep vein). 
Stenosis of the iliac vein was observed in 43 cases,
whereas iliofemoral vein occlusion, which included
common iliac vein occlusion (33 cases) and occlusion of the
common and external iliac vein (49 cases), was observed in
82 cases (65.6%). Contrast stasis and emptying delay was
observed in 122 cases (97.6%) by venography. Moreover,
124 cases (99.2%) had collateral circulation.
Interventional Treatment
We treated 39 IVCS patients without DVT as follows: we
accessed the femoral via local anesthesia and the
subsequent insertion of a F4-F5 sheath. Next, we passed a
H1 catheter (Cordis Corporation, Miami, FL), and guide
wire (Terumo Corporation, Tokyo, Japan) through the
stenosis lesion and advanced them up to the inferior vena
cava. In addition, we exchanged the H1 catheter with a
multi-sidehole catheter (Cook, Bloomington, IN) followed
by performing a venography of the iliac vein and inferior
vena cava to assess the location and severity of the iliac
vein stenosis or occlusion and ensure that the catheter was
positioned in the real lumen. A F6-F7 sheath was
exchanged in an 8-12 mm diameter balloon catheter (C.R.
Bard, Murray Hill, NJ) was inflated for 20-30 seconds at
the usual 6-10 ATM, to treat the iliac vein stenosis or
occlusion. For patients with more than 30% residual
stenosis, a 10-16 mm diameter self-expandable stent
(Luminexx, C.R. Bard, Murray Hill, NJ) should be placed
for patients with 3-4 mm of the cephalad end of the stent
placed into the inferior vena cava. We performed post-
stenting dilatation for patients with intra-stent stenosis.
Of the 125 cases of IVCS, 86 employed an alternative
strategy according to their course, features and position of
the DVT as well as the angiograms of the femoral popliteal
veins. The definition of fresh thrombus consisted of the
intraluminal-filling defect and double track sign in a
venography. In addition, the aspirated thrombus was soft
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Table 1. Demographic Data of Patients (n = 125)
FactorsNo. of Patients  (% Total)
Female gender 075 (60.0%)
Age  40 years 072 (57.6%)
Immobilization 013 (10.4%)
Postpartum 007 (5.6%)
Lower extremity swelling 115 (92.0%)
Pain 101 (80.8%)
Varicose vein 031 (24.8%)
Without thrombosis 039 (31.2%)
With fresh thrombosis 052 (41.6%)
With non-fresh thrombosis 034 (27.2%)and red, or less than 14 days of symptoms.
According to the DSA road map or ultrasound guidance,
followed by other procedures described above, 11 central
type DVT cases (> 2 weeks, without fresh thrombosis)
experienced a punctured popliteal vein. Next, a self-
expandable stent was implanted. The distal end of the stent
was higher than the femoral vein. 
In the 23 mixed DVT cases (> 2 weeks, without fresh
thrombosis), the femoral vein in the normal side or the
right internal jugular vein was accessed for the implanta-
tion of the catheter into to iliofemoral vein, followed by a
percutaneous transluminal angioplasty (PTA) in the lesion.
In 13 of the 23 cases, which experienced higher blood flow
in femoral or external iliac vein, a self-expandable stent
was implanted. The remaining 10 cases with lower blood
flow in the femoral vein, we only performed a PTA to
treat the iliofemoral vein. 
If fresh thrombus was found in central DVT patients (15
case), a retrievable filter (n = 8) was inserted in patients
with less than 14 days of symptoms or a permanent filter
(n = 7) in patients with more than 14 days of symptoms via
the contralateral femoral vein, jugular vein or antecubital
vein. After accessing the popliteal vein, we advanced the
H1 catheter and guide wire through the stenosis lesion, up
to the inferior vena cava. In addition, we exchanged in a
long sheath or guiding catheter, through which we
suctioned the thrombosis in the iliac and femoral veins.
When a relatively large quantity of thrombosis was
present, we performed a mechanical thrombectomy via a
Clot Buster Thrombectomy Device (ev3, Plymouth, MN)
or a Straub Rotarex system (SRS, Straub Medical AG,
Switzerland). Next, we performed PTA and self-expand-
able stenting in the iliac vein.
If fresh thrombus was found in the mixed DVT patients
(37 cases), a retrievable filter (n = 9) was inserted in
patients with less than 14 days of symptoms, or a
permanent filter (n = 28) in patients with more than 14
days of symptoms via contralateral femoral vein. We used
a C3 catheter (Cordis Corporation, Miami, FL) through the
filter carrier sheath to find the mouth of the affected
common iliac vein. Once the catheter attained the external
iliac vein, a H1 catheter was exchanged in and advanced
down to the femoral-popliteal vein, followed by exchang-
ing in an 8 Fr long sheath (Arrow International Inc.,
Reading, PA), through which thrombosis suction was
performed in the popliteal, femoral and iliac vein using the
8 Fr guiding catheter (Cordis Corporation, Miami, FL). If
excessive residual thrombus was present, we performed a
mechanical thrombectomy (such as Clot Buster thrombec-
tomy device or SRS). Next, we performed a PTA and self-
expandable stenting for the residual stenosis found in the
iliac vein.
All patients were observed using a blood coagulation
function monitor when practicing anticoagulation and
thrombolytic therapy. We injected the patients with low
molecular heparin (Nadroparin, GlaxoSmithKline, Tianjin,
China) twice a day for 3-5 days (4,100 IU abdominal
subcutaneous injection) as well as Warfarin (1.25-5.00 mg
orally) once per day for 1-6 months. We treated patients
implanted with a permanent filter with warfarin for a
longer time than patients with temporary filters. For
patients with fresh thrombus who were undergoing
thrombus aspiration or mechanical thrombectomy, we kept
a multi-sidehole catheter for 3-5 days of thrombolysis
and/or 5-7 days of antegrade thrombolysis. We adminis-
tered a daily urokinase dose of approximately 250,000-
1,000,000 units. In addition, the patient took a 75-300 mg
daily dose of Aspirin for 6-12 months. We also monitored
for blood coagulation to provide evidence for adjustments
in medication dose. 
Assessment of Effect
Seventy-eight cases had follow-up data. Each patient was
followed by clinical symptom (edema and pain) at 1, 3, 6
and 12 months after discharge and annually thereafter. At
six months after discharge, we performed a venography.
The average follow-up period was 10.2±0.3 months
(range: 0.5-3.0 yrs). We lost 47 cases to follow-up. Based
on the comparison of the symptoms and the venography
performed prior to and six months after discharge, the
clinical effect was graded into four classes as follows:
Excellent: disappearance of edema and pain; blood flow
completely restored on venography; disappearance of
collateral vein; no contrast stasis; and the vessel wall was
smooth. Good: edema and/or pain; blood flow completely
restored on venography; no collateral vein remained; no
contrast stasis; and the vessel wall was smooth. Moderate:
edema and/or pain; blood flow partially restored (greater
than 50% patency rate in stent) on venography; collateral
vessels remained; contrast stasis or the vessel wall was not
smooth. Poor: no improvement of symptoms; no recovery
of blood flow on venography; collateral vein was the main
route of blood flow.
Group 1 included IVCS patients without thrombosis,
whereas group 2 included IVCS patients with fresh
thrombus and group 3 included IVCS patients with non-
fresh thrombus and the effect of the procedure was
assessed for each group, respectively.
Definition
We defined a technical success as the restoration of
continuous inline flow with the abolition of collaterals
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vena cava. We defined an effective case as a complete or a
greater than 50% patency rate for the stenting, and
included patients classified as excellent, good and
moderate. Patency was defined as the inline flow through
the implanted stent segment, into the inferior vena cava,
without contrast stasis and emptying delay, and including
patients classified as “excellent” and “good”.
We performed all statistical calculations using the SPSS
software package, version 13.0 (SPSS Software Inc,
Chicago, IL). We used the 
2 test to determine the presence
of a statistical difference. For the three groups, we used a
p-value of less than 0.05 as a threshold for statistical signif-
icance, and a p-value of less than 0.05 to indicate a statisti-
cal difference between the two groups.
RESULTS
The overall technical success rate of the treatment was
97% (121 of 125 cases). Moreover, the balloon diameter
ranged from 8 to 12 mm, with a length ranging from 20 to
40 mm. The stent diameter ranged from 10 to 16 mm, with
a length ranging from 60 to 90 mm.
Among the 39 IVCS cases belonging to group 1, 38
(97.4%) had stenting in the iliac vein stenosis (n = 20) and
occlusion (n = 18) (Fig. 1), either at pre-stent balloon
dilatation (n = 21) or post-stent dilatation (n = 6). In one
case, the catheter and wire failed to pass the lesion, which
rendered PTA and stenting impossible. The clinical evalua-
tions before discharge were classified as: “Excellent” - 21
(53.8%), “Good” - 16 (41.0%), “Moderate” - one (2.6%),
and “Poor” - one (2.6%).  Overall, the effective rate was
97% (38 of 39 cases), and the patency rate was 95% (37
of 39 cases). In 27 of 39 cases (69.2%), patients were kept
for obtaining follow-up data. The assessment of the effect
at six months after discharge was as follows: 16 (59.3%)
patients were “Excellent”; nine (33.3%) patients were
“Good”; one (3.7%) patient was “moderate” and 1 (3.7%)
patient was “poor”. The effective rate was 96% (26 of 27
cases) and the patency rate was 93% (25 of 27 cases).
Among the 86 IVCS cases with iliofemoral vein
thrombosis, we performed a thrombosis aspiration or
mechanical thrombectomy in 83 cases (96.5%). Further,
we performed PTA (n = 67) and stenting (n = 73) in cases
of stenosis or occlusion of the iliac vein (Fig. 2), both at
pre- and post-stent dilatation (post-stent performed in one
patient). The catheter and wire failed to pass the occlusion
in three cases. This rendered the mechanical thrombec-
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Table 3. Effective Rate and Patency Rate Comparison at Six Months Follow-up (n = 78)
Assessment of Effect Effective  Patency
Excellent Good Moderate Poor
Total
Rate (%) Rate (%)
Group 1 16 09 1 1 27 96.3 92.6
Group 2 09 15 4 1 29 96.6 82.8
Group 3 06 05 7 4 22 81.8 50.0
2 4.750 13.274
P 0.093 0.001
Note.─ Group 1 = iliac vein compression syndrome without thrombosis, group 2 = iliac vein compression syndrome with fresh thrombosis, group 3 = iliac 
vein compression syndrome with non-fresh thrombosis. No significant difference was observed for patency rates between group 1 and group 2 (
2 = 0,501,
p = 0.479). Conversely, significant difference was observed for patency rates between group 1 and group 3 (
2 = 11,282, p = 0.001) and between group 2
and group 3 (
2 = 6,235, p = 0.013).
Table 2. Effective Rate and Patency Rate Comparison at Discharge (n = 125)
Assessment of Effect
Total
Effective  Patency 
Excellent Good Moderate Poor Rate (%) Rate (%)
Group 1 21 16 01 1 39 97.4 94.9
Group 2 20 26 05 1 52 98.1 88.5
Group 3 08 14 10 2 34 94.1 64.7
2 1.114 13.617
P 0.573 0.001
Note.─ Group 1 = iliac vein compression syndrome without thrombosis, group 2 = iliac vein compression syndrome with fresh thrombosis, group 3 = iliac 
vein compression syndrome with non-fresh thrombosis. No significant difference in patency rates were observed between group 1 and group 2 (
2 = 0.483,
p = 0.487). Conversely, significant difference was observed for patency rate between group 1 and group 3 (
2 = 10,664, p = 0.001) and between group 2
and group 3 (
2 = 7,010, p = 0.008).tomy, PTA and stenting impossible, and consequently,
thrombus aspiration only was performed for these three
patients. Twelve of the 17 retrievable filters were retrieved
within 10 days of the procedure, whereas the other five
filters were kept inside because the thrombus lot was
found in the iliac vein. 
Of the clinical evaluations of patients belonging to group
2 (n = 52) performed before discharge, 20 (38.5%) were in
“excellent” condition, 26 (50.0%) were in “good”
condition, five (9.6%) were in “moderate” condition, and
one (1.9%) patient was in “poor” condition. The effective
rate was 98% and the patency rate was 89%. Moreover,
29 of the 52 (55.8%) patients belonging to group 2 were
followed-up. At  six months after being discharged, nine
(31.0%) patients were in “excellent” condition, 15
(51.7%) were in “good” condition, four (13.8%) were in
“moderate” condition and one (3.4%) patient was in
“poor” condition. The effective rate was 97% and the
patency rate was 83%. The clinical evaluation of the
patients belonging to group 3 (n = 34) before discharge
found that eight (23.5%) patients were in “excellent”, 14
(41.2%) were in “good” condition, 10 (29.4%) were in
“moderate” condition and two (5.9%) were in “poor”
condition. The effective rate was 94% and the patency rate
was 65%. Of the 34 patients belonging to group 3, 22
(64.7%) possessed follow-up data. The six month follow-
up indicated that six (27.3%) patients were in “excellent”
condition, five (22.7%) were in “good” condition; seven
(31.8%) were in “moderate” condition and four (18.2%)
were in “poor” condition. The effective rate was 82% and
the patency rate was 50%. A detailed assessment is
recorded in Tables 2, 3.
The initial effective rate between the three groups
revealed no significant difference (p = 0.573). However,
the difference in the initial patency rates between groups
were found to be statistically significant (p = 0.001).
Moreover, the initial patency rates of group 1 (94.9% vs.
64.7%, p = 0.001) or group 2 (88.5% vs. 64.7%, p =
0.008) was greater than the patency rate recorded in group
3. No significant difference was found for the initial
patency rate between group 1 and group 2 (94.9% vs.
88.5%, p = 0.487). Consistently, the results from the six
month follow-up period were similar, with no significant
difference in the effective rate between the three groups (p
= 0.093). Further, a more favorable patency was observed
in group 1 (92.6% vs. 50.0%, p = 0.001) and group 2
(82.8% vs. 50.0%, p = 0.013).
No complications (i.e. bleeding and hematoma, stent
migration, acute thrombosis) occurred during the stenting
procedure. Moreover, no cases of pulmonary embolism
(PE) were recorded for all 125 patients (in hospital) and
the 78 patients from the procedure to the 6-month follow-
up period. We observed one case of inferior vena cava
obstruction from a patient with an inferior vena cava filter
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Fig. 1. Treatment of iliac vein compres-
sion syndrome without deep vein
thrombosis.
A. Venography showing compressed
left common iliac vein (black arrow) and
contralateral venous drainage via pelvic
venous collaterals (white arrow).
B. Venography after stenting showing
widely patent left common iliac vein.
AB6-month post-treatment angiogram results). However, we
restored the inferior vena cava blood flow following
aspiration and a mechanical thrombectomy. In two IVCS
patients with recurrent DVT present (3 and 6 months after
discharge follow-up evaluation showing the in-stent
obstruction), blood flow was successfully restored in one
case by PTA and not in the other due to the inability to
pass the catheter and wire beyond the obstruction. 
Of the 12 patients with a confirmed IVCS during a
preoperative examination for the stripping or endovascular
closure of the great saphenous vein symptoms were
relieved in four cases within 3-6 months. The other eight
cases experienced no remarkable improvement. We
performed five laser and radiofrequency closures in the
great saphenous. For the follow-up period, all 12 patients
were free of the symptoms associated with DVT. Leg
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Fig. 2. Treatment of iliac vein compres-
sion syndrome with deep vein thrombo-
sis.
A. Venography showing thrombosis
(fresh thrombus and 8 days after onset)
and occlusion of left iliofemoral vein as
well as contralateral venous drainage
via pelvic venous collaterals.
B. Venography after thrombectomy and
stenting showing patent left femoral vein
and in-stent stenosis due to iliac vein
compression (black arrow).
C. Venography after intra-stent percuta-
neous transluminal angioplasty showing
widely patent left common iliac vein.
D. Venography one year after retrieval
of filter showing remaining patent inferior
vena cava and left iliofemoral vein.
AB
CDswelling was diminished after PTA and stenting in nine
cases in which IVCS was found by venography because of
aggravation of symptoms after great saphenous vein
surgery. The remaining 18 cases with isolated IVCS
showed an improvement in symptoms in 16 cases.
DISCUSSION
Iliac vein compression is a frequent anatomic variant.
The right common iliac artery crosses over the left
common iliac vein and then reaches the outside of right
iliac vein, where it continues to the right external iliac
artery, which is parallel to the right external iliac vein,
behind the left iliac vein there are sacral promontory or the
fifth lumbar vertebra. The causes of IVCS include the
combination of compression and vibratory pressure in the
right iliac artery on the iliac vein, which results in the
pinching of the iliac vein between the artery and the pelvic
bone. The two walls of the vein rub against each other,
which lead to irritation of the endothelium. Moreover, this
irritation led to the proliferation of the endothelium,
synechiae or spurs and the formation of a partition in the
lumen. Further, it may cause chronic symptoms of left-side
venous hypertension including edema, leg heaviness, skin
discoloration, pain, varicose veins or ulceration. In
addition, it may frequently lead to thrombosis when the
stenosis of the iliac vein is greater than 50%. IVCS and
subsequent thrombosis occurs more commonly on the left
side. In our study, IVCS occurred 4.6 times more
frequently on the left side than the right side, whereas
IVCS with thrombosis occurred 4.7 times more frequently
on the left side than the right, This difference in frequency
suggests that the results are consistent with the published
literature (1-3).
It is difficult to find isolated iliac vein compression
without thrombosis in a clinical setting, but it does not
indicate the low incidence of iliac vein compression.
Recent imaging reports have demonstrated that at least a
25% compression of the left iliac vein at the arterial
crossover point may be present in 66% of the asympto-
matic patient population (8). This correlates with nearly a
50% reduction in the total cross-sectional areas of the vein.
Previous reports have suggested that this anatomic variant
may predispose the formation of deep venous thrombosis.
Virchow’s Triad describes an increased risk of venous
thrombosis with stasis, hypercoagulability and vessel
intimal injury, the first of which is present with any venous
obstruction disease including IVCS. There is evidence to
suggest that intimal injury may also take place in the form
of a spur when the compression occurs over time. These
will increase the risk for the development of DVT. Raju
and Neglen (9) proposed that the development is probably
a slow, progressive condition. Fluid balance in the limb is
on the edge during orthostasis; however, many patients
remain asymptomatic until the progressive hemodynamic
deterioration across a certain critical threshold including
surgery as well as pregnancy and prolonged immobiliza-
tion had been mentioned as contributory factors contribut-
ing to patients with asymptomatic lesions and should be
educated and followed-up on closely for the early identifi-
cation of acute occlusion. From the accounts above, we
emphasize that the evaluation of the iliac vein in the
patients presenting with unilateral lower extremity edema
and/or varicose veins, especially in the preoperative
examination of the great saphenous stripping and early
recognition of iliac vein compression, which may prevent a
DVT and provide symptomatic relief.
The successful treatment of IVCS would involve a
combination of several interventional techniques to
remove as much of the iliofemoral vein thrombosis as
possible. Thus, deep vein blood flow can be restored and
the course can be shortened. Also, it can prevent or reduce
the valve dysfunction of the popliteal and calf vein, as well
as reduce the incidence of post thrombosis syndrome. A
clot Buster thrombectomy device and SRS work well with
the acute thrombus present in iliofemoral vein (10-14).
SRS is also effective in dealing with subacute iliofemoral
thrombosis. An endovascular mechanical thrombectomy,
combined with guiding catheter suction, can substitute
most of the surgical embolectomy. However, neither the
Clot Buster thrombectomy device nor the SRS can be used
to deal with DVT bellow popliteal vein, which needs
embolectomy from posterior tibial vein incision.
The use of an inferior vena cava filter to prevent fatal
PEs is still controversial, Decousus et al. (15) published the
only randomized study for vena cava filters in 1998. The
results indicated that a significant decrease in the incidence
of PE compared with anticoagulation alone (1.1% vs.
4.8%, p = 0.03) at 8 to 12 days of follow-up. After two
years, this difference was no longer statistically significant
(3.4% vs. 6.3%, p = 0.16). In contrast, vena caval filters
were associated with significantly more recurrent DVT
than anticoagulation alone (20.8% vs. 11.6%, p = 0.02). If
there are large amounts of fresh thrombus in the
iliofemoral vein before PTA, an inferior vena cava filter
should be inserted to prevent of thrombus shedding, which
may lead to a fatal PE (16-18). There are many different
types of inferior vena cava filters; the retrievable filter may
be the best choice for acute thrombosis since it can be
retrieved after thrombolysis or a thrombectomy to prevent
the filter related complication.
Recent reports have shown that stenting of the iliac vein
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improve the long-term outcome of patients after a
thrombectomy or thrombolysis of left-side acute DVT (19-
23). In this series, both the initial and six month patency
rates in IVCS patients, without thrombus or with fresh
thrombus, had significantly greater patency rates than
IVCS patients with non-fresh thrombus. This demonstrates
that the early recognition and management of iliac vein
compression would achieve a more favorable outcome. In
addition, we mentioned that some patients did not experi-
ence complete symptomatic relief, even though the patient
achieved complete patency for the iliofemoral vein. We
believe that this may be attributed to an increase in venous
reflux after iliofemoral stenting (24, 25). Delis et al. (24)
reported successful patency results after stenting, despite
the deterioration of reflux and improved venous claudica-
tion associated with successful stent recanalization in the
limbs, which normalizes venous outflow, enhances the calf
muscle pump function and leads to a significant improve-
ment in clinical outcome. We suggest that the enhanced
postoperative stocking is pivotal in preventing disease
progression and outcome improvement.
The limitations of this study involve its retrospective
nature, the limited number of isolated iliac vein compres-
sion patients evaluated, and the relatively short follow-up
period. These lower the relevance among iliac vein
compression, incidence of deep venous thrombosis due to
iliac vein compression, and the success of early treatment
in relation to the longer-term outcome. Thus, we need to
perform a prospective control study with a large sample
size.
In conclusion, the data obtained from the evaluated
patients suggest that endovascular treatment for IVCS,
with or without thrombosis, is safe and effective. This
study shows a superior patency rate in IVCS patients
without thrombosis and with fresh thrombosis when
compared to IVCS patients with non-fresh thrombosis. We
suggest the reconstruction of the evaluation for the
occurrence of iliac vein compression in patients with unilat-
eral lower extremity edema and preoperative examina-
tions indicating the presence of varicose veins. Early
recognition and endovascular treatment of iliac vein
compression could prevent a DVT and an improvement in
the symptoms.
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